OTCMKTS:IGXT
Delisted

Intelgenx Technologies Stock News

etoro logo Buy IGXT
*Your capital is at risk
$0.170
+0 (+0%)
At Close: Aug 26, 2025
IntelGenx Technologies Corp. (OTCQB:IGXT) Q4 2022 Earnings Conference Call March 29, 2023 4:30 PM ET Company Participants Stephen Kilmer – Investor Relations Horst Zerbe – Chief Executive Officer
SAINT LAURENT, Quebec, March 24, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that, further to its
SAINT LAURENT, Quebec, March 23, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it will release
IntelGenx Technologies Corp. (OTCQB:IGXT) Q3 2022 Earnings Conference Call November 11, 2022 8:00 PM ET Company Participants Stephen Kilmer - Investor Relations Horst Zerbe - Chief Executive Officer A
SAINT LAURENT, Quebec, Nov. 10, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that its third quarter
SAINT LAURENT, Quebec, Nov. 03, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it will release i
IntelGenx Technologies Corp. (OTCQB:IGXT) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Stephen Kilmer – Investor Relations Horst Zerbe – Chief Executive Officer
IntelGenx Technologies Corp. (OTCQB:IGXT) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Horst Zerbe – Chief Executive Officer André Godin – President and Chief Fin
SAINT LAURENT, Quebec, May 05, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it will release it
SAINT LAURENT, Quebec, April 26, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that management will
IntelGenx Technologies Corp. (IGXT) CEO Horst Zerbe on Q4 2021 Results - Earnings Call Transcript
SAINT LAURENT, Quebec, March 17, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it will release

Psychedelic Stock Gainers And Losers From February 17, 2022

09:55pm, Thursday, 17'th Feb 2022 Benzinga
GAINERS: Mindset Pharma (OTC: MSSTF ) shares closed up 9.89% at $0.55 Small Pharma (OTC: DMTTF ) shares closed up 5.33% at $0.23 Intelgenx Technologies (OTC: IGXT ) shares closed up 1.06% at $0.32 LOSERS: ATAI Life Sciences (NASDAQ: ATAI ) shares closed down 8.49% at $5.71 Field Trip Health (NASDAQ: Full story available on Benzinga.com
GAINERS: Allied (OTC: ALID ) shares closed up 16.57% at $2.11 Filament Health (OTC: FLHLF ) shares closed up 11.49% at $0.30 GH Research (NASDAQ: GHRS ) shares closed up 1.59% at $19.21 LOSERS: Intelgenx Technologies (OTC: IGXT ) shares closed down -6.13% at $0.34 Small Pharma (OTC: DMTTF ) shares closed down -4.97% at $0.18 ATAI Life Full story available on Benzinga.com
IntelGenx Technologies Corp. (IGXT) CEO Horst Zerbe on Q3 2021 Results - Earnings Call Transcript
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE